As a result of the continuing global uncertainty caused by the COVID-19 pandemic, TRICALS has taken the difficult decision to postpone the TRICALS Masterclass 2020 until further notice. We are now working find a suitable date for this event in 2021. More details will be announced on our website through our newsletter
Related news
Apellis reports discontinuation of MERIDIAN study
Pharmaceutical company Apellis has announced the discontinuation of the open-label phase of […]
Recording of virtual meeting - Adherence and retention in ALS clinical trials
On March 22, 2023, TRICALS organised its first virtual meeting: ‘Adherence and retention […]
COURAGE-ALS trial discontinued due to disappointing results
The company Cytokinetics has announced early termination of the COURAGE-ALS study. An […]
TRICALS consensus statement on Tofersen
OPINION: The consensus view of TRICALS neurologists is that Tofersen shows clear […]